

(Sharecast News) - Specialist drug developer Sareum Holdings updated the market on the development of its 'SDC-1801' - a potential Covid-19 and autoim...


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:


IN BRIEF: Drug maker Sareum plans 50-into-1 share consolidation


IN BRIEF: Sareum raises GBP1.6 million to advance inhibitor programmes


UK shareholder meetings calendar - next 7 days


DIRECTOR DEALINGS: New MaxCyte chair buys USD220,000 in shares


Sareum full-year loss widens on research & development costs